REQUEST A DEMO
Total
USD $0.00
Search more companies

Hemofarm A.D. Vrsac (Serbia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hemofarm A.D. Vrsac Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Serbia's pharmaceuticals maker Hemofarm was established in 1960. Its portfolio includes more than 150 products divided into three main categories - Medical products prescription (Rx), Over the counter medicinal products (Otc) and Dietary supplements. The company's headquarters and the key production facility are in the northern Serbian town of Vrsac. It also has manufacturing activities in Dubovac, Podgorica, Sabac and Banja Luka. The drug maker operates in more than 30 countries on 3 continents with more than 80,000 square meters manufacturing and business area.

Headquarters
Beogradski Put Bb
Vrsac; South Banat; Postal Code: 26300

Contact Details: Purchase the Hemofarm A.D. Vrsac report to view the information.

Website: http://www.hemofarm.com

Basic Information
Total Employees:
Purchase the Hemofarm A.D. Vrsac report to view the information.
Outstanding Shares:
Purchase the Hemofarm A.D. Vrsac report to view the information.
Registered Capital:
Purchase the Hemofarm A.D. Vrsac report to view the information.
Financial Auditors:
Purchase the Hemofarm A.D. Vrsac report to view the information.
Incorporation Date:
August 28, 1998
Key Executives
Purchase this report to view the information.
Acting General Director
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Fondacija Hemofarm
100%
Velexfarm D.O.O. Beograd
100%
Company Performance
Financial values in the chart are available after Hemofarm A.D. Vrsac report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
18.33%
Total operating revenue
14.02%
Operating profit (EBIT)
7.94%
EBITDA
8.41%
Net Profit (Loss) for the Period
-11.78%
Total assets
10.97%
Total equity
8.03%
Operating Profit Margin (ROS)
-0.92%
Net Profit Margin
-2.4%
Return on Equity (ROE)
-1.68%
Debt to Equity Ratio
6.14%
Quick Ratio
-0.01%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?